UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

Adult and pediatric relapsing multiple sclerosis phase II and phase III trial design and their primary end points: A systematic review

Clinical and translational science, 2024-05, Vol.17 (5), p.e13794-n/a

2024

Volltextzugriff (PDF)

The Prevalence and Diagnostic Ratio of Familial Hypercholesterolemia (FH) and Proportion of Acute Coronary Syndrome in Japanese FH Patients in a Healthcare Record Database Study

Cardiovascular therapeutics, 2020, Vol.2020, p.5936748-9

2020

Volltextzugriff (PDF)

Rationale, study design, baseline characteristics and blood pressure at 16 weeks in the HONEST Study

Hypertension research, 2013-02, Vol.36 (2), p.177-182

2013

Volltextzugriff (PDF)

Clinical Status and Outcome of Japanese Heart Failure Patients With Reduced or Preserved Ejection Fraction Treated With Carvedilol

International Heart Journal, 2013, Vol.54(1), pp.15-22

2013

Volltextzugriff (PDF)

Efficacy and safety of dimethyl fumarate in treatment-naïve Japanese patients with multiple sclerosis: Interim analysis of the randomized placebo-controlled study

Multiple sclerosis journal - experimental, translational and clinical, 2019-04, Vol.5 (2), p.2055217319852727-2055217319852727

2019

Volltextzugriff (PDF)

Risk factors for primary prevention of cardiovascular disease and risk reduction by lipid control: the OMEGA study risk factor sub-analysis

Clinical and experimental hypertension (1993), 2014-01, Vol.36 (4), p.236-243

2014

Volltextzugriff (PDF)

Inhibitory Effects of Azelnidipine Tablets on Morning Hypertension

Drugs in R&D, 2013-03, Vol.13 (1), p.63-73

2013

Volltextzugriff (PDF)

Current Status, Challenges, and Future Perspectives of Real-World Data and Real-World Evidence in Japan

Drugs -- real world outcomes, 2021-12, Vol.8 (4), p.459-480

2021

Volltextzugriff (PDF)

Early Antihypertensive Efficacy of Olmesartan Medoxomil

The journal of clinical hypertension (Greenwich, Conn.), 2008-12, Vol.10 (12), p.930-935

2008

Volltextzugriff (PDF)

72-Week Safety and Tolerability of Dimethyl Fumarate in Japanese Patients with Relapsing-remitting Multiple Sclerosis: Analysis of the Randomised, Double Blind, Placebo-Controlled, Phase III APEX Study and its Open-Label Extension

Advances in therapy, 2018-10, Vol.35 (10), p.1598-1611

2018

Volltextzugriff (PDF)

A New Baroreceptor Sensitivity-Restoring Ca-Channel Blocker Diminishes Age-Related Morning Blood Pressure Increase in Hypertensive Patients: Open-Label Monitoring of Azelnidipine Treatment for Hypertension in the Early Morning (At-HOME) Study

Pharmaceuticals (Basel, Switzerland), 2010-01, Vol.3 (1), p.225-236

2010

Volltextzugriff (PDF)

The Prevalence and Diagnostic Ratio of Familial Hypercholesterolemia

Cardiovascular therapeutics, 2020-06, Vol.2020

2020

Volltextzugriff (PDF)

Insights on diagnosis and therapeutic decision-making patterns for multiple sclerosis treatment: cross-sectional opinion survey results from Japanese neurologists

Multiple sclerosis and demyelinating disorders, 2018-06, Vol.3 (1), p.1, Article 4

2018

Volltextzugriff (PDF)

Rationale, study design, baseline characteristics and blood pressure at 16 weeks in the HONEST Study

Hypertension research, 2013-02, Vol.36 (2), p.177-182

2013

Volltextzugriff (PDF)

Adalimumab discontinuation in patients with early rheumatoid arthritis who were initially treated with methotrexate alone or in combination with adalimumab: 1 year outcomes of the HOPEFUL-2 study

Rheumatic & musculoskeletal diseases open, 2016-01, Vol.2 (1), p.e000189-e000189

2016

Volltextzugriff (PDF)

Relationship between achieved blood pressure, dietary habits and cardiovascular disease in hypertensive patients treated with olmesartan: the OMEGA study

Hypertension research, 2012-12, Vol.35 (12), p.1136-1144

2012

Volltextzugriff (PDF)

513 HONEST (HOME BLOOD PRESSURE MEASUREMENT WITH OLMESARTAN NAIVE PATIENTS TO ESTABLISH STANDARD TARGET BLOOD PRESSURE) STUDY. RATIONALE, DESIGN, AND BASELINE CHARACTERISTICS

Journal of hypertension, 2012-09, Vol.30 (Supplement 1), p.e151

2012

Volltextzugriff (PDF)

Enhanced Blood Pressure–Lowering Effect of Olmesartan in Hypertensive Patients With Chronic Kidney Disease–Associated Sympathetic Hyperactivity: HONEST Study

The journal of clinical hypertension (Greenwich, Conn.), 2013-08, Vol.15 (8), p.555-561

2013

Volltextzugriff (PDF)

Erratum: Relationship between achieved blood pressure, dietary habits and cardiovascular disease in hypertensive patients treated with olmesartan: the OMEGA study

Hypertension research, 2012-12, Vol.35 (12), p.1203-1203

2012

Volltextzugriff (PDF)

Relationship between achieved blood pressure, dietary habits and cardiovascular disease in hypertensive patients treated with olmesartan: the OMEGA study

Hypertension research, 2012-12, Vol.35 (12), p.1203-1203

2012

Volltextzugriff (PDF)

Study of Sustained Blood Pressure-Lowering Effect of Azelnidipine Guided by Self-Measured Morning and Evening Home Blood Pressure: Subgroup Analysis of the At-HOME Study

Drugs in R&D, 2013-03, Vol.13 (1), p.75-85

2013

Volltextzugriff (PDF)

Olmesartan medoxomil and azelnidipine therapy in patients with hypertension and chronic kidney disease in Japan

Journal of nephrology, 2012-09, Vol.25 (5), p.699-708

2012

Volltextzugriff (PDF)

Effect of Methotrexate Plus Adalimumab on the Achievement of Rheumatoid Arthritis Therapeutic Goals: Post Hoc Analysis of Japanese Patients (MELODY Study)

Rheumatology and therapy., 2016-06, Vol.3 (1), p.129-141

2016

Volltextzugriff (PDF)

Estimating Antihypertensive Effects of Combination Therapy in an Observational Study Using Marginal Structural Models

Biometrical journal, 2009-10, Vol.51 (5), p.789-800

2009

Volltextzugriff (PDF)

The Use of Olmesartan Medoxomil as Monotherapy or in Combination With Other Antihypertensive Agents in Elderly Hypertensive Patients in Japan

The journal of clinical hypertension (Greenwich, Conn.), 2008-04, Vol.10 (4), p.272-279

2008

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(37)
Buchkapitel
(1)

Sprache

Englisch
(34)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(22)
Science & Technology
(22)
Humans
(20)
Aged
(17)
Female
(17)
Male
(16)
Middle Aged
(14)
Blood Pressure - Drug Effects
(13)
Hypertension - Drug Therapy
(13)
Aged, 80 And Over
(12)
Prospective Studies
(12)
Adult
(10)
Cardiovascular System & Cardiology
(10)
Treatment Outcome
(10)
Hypertension - Physiopathology
(9)
Imidazoles - Therapeutic Use
(9)
Pharmacology & Pharmacy
(9)
Tetrazoles - Therapeutic Use
(9)
Antihypertensive Agents - Therapeutic Use
(8)
Hypertension
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Adult and pediatric relapsing multiple sclerosis phase II and phase III trial design and their primary end points: A systematic review

The Prevalence and Diagnostic Ratio of Familial Hypercholesterolemia (FH) and Proportion of Acute Coronary Syndrome in Japanese FH Patients in a Healthcare Record Database Study

Rationale, study design, baseline characteristics and blood pressure at 16 weeks in the HONEST Study

Clinical Status and Outcome of Japanese Heart Failure Patients With Reduced or Preserved Ejection Fraction Treated With Carvedilol

Efficacy and safety of dimethyl fumarate in treatment-naïve Japanese patients with multiple sclerosis: Interim analysis of the randomized placebo-controlled study

Risk factors for primary prevention of cardiovascular disease and risk reduction by lipid control: the OMEGA study risk factor sub-analysis

Inhibitory Effects of Azelnidipine Tablets on Morning Hypertension

Current Status, Challenges, and Future Perspectives of Real-World Data and Real-World Evidence in Japan

Early Antihypertensive Efficacy of Olmesartan Medoxomil

72-Week Safety and Tolerability of Dimethyl Fumarate in Japanese Patients with Relapsing-remitting Multiple Sclerosis: Analysis of the Randomised, Double Blind, Placebo-Controlled, Phase III APEX Study and its Open-Label Extension

A New Baroreceptor Sensitivity-Restoring Ca-Channel Blocker Diminishes Age-Related Morning Blood Pressure Increase in Hypertensive Patients: Open-Label Monitoring of Azelnidipine Treatment for Hypertension in the Early Morning (At-HOME) Study

The Prevalence and Diagnostic Ratio of Familial Hypercholesterolemia

Insights on diagnosis and therapeutic decision-making patterns for multiple sclerosis treatment: cross-sectional opinion survey results from Japanese neurologists

Rationale, study design, baseline characteristics and blood pressure at 16 weeks in the HONEST Study

Adalimumab discontinuation in patients with early rheumatoid arthritis who were initially treated with methotrexate alone or in combination with adalimumab: 1 year outcomes of the HOPEFUL-2 study

Relationship between achieved blood pressure, dietary habits and cardiovascular disease in hypertensive patients treated with olmesartan: the OMEGA study

513 HONEST (HOME BLOOD PRESSURE MEASUREMENT WITH OLMESARTAN NAIVE PATIENTS TO ESTABLISH STANDARD TARGET BLOOD PRESSURE) STUDY. RATIONALE, DESIGN, AND BASELINE CHARACTERISTICS

Enhanced Blood Pressure–Lowering Effect of Olmesartan in Hypertensive Patients With Chronic Kidney Disease–Associated Sympathetic Hyperactivity: HONEST Study

Erratum: Relationship between achieved blood pressure, dietary habits and cardiovascular disease in hypertensive patients treated with olmesartan: the OMEGA study

Relationship between achieved blood pressure, dietary habits and cardiovascular disease in hypertensive patients treated with olmesartan: the OMEGA study

Study of Sustained Blood Pressure-Lowering Effect of Azelnidipine Guided by Self-Measured Morning and Evening Home Blood Pressure: Subgroup Analysis of the At-HOME Study

Olmesartan medoxomil and azelnidipine therapy in patients with hypertension and chronic kidney disease in Japan

Effect of Methotrexate Plus Adalimumab on the Achievement of Rheumatoid Arthritis Therapeutic Goals: Post Hoc Analysis of Japanese Patients (MELODY Study)

Estimating Antihypertensive Effects of Combination Therapy in an Observational Study Using Marginal Structural Models

The Use of Olmesartan Medoxomil as Monotherapy or in Combination With Other Antihypertensive Agents in Elderly Hypertensive Patients in Japan

Suchergebnisse filtern